0001209191-12-016968.txt : 20120308
0001209191-12-016968.hdr.sgml : 20120308
20120308185640
ACCESSION NUMBER: 0001209191-12-016968
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120301
FILED AS OF DATE: 20120308
DATE AS OF CHANGE: 20120308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DRISCOLL FREDERICK W
CENTRAL INDEX KEY: 0001129890
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26770
FILM NUMBER: 12678584
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVAVAX INC
CENTRAL INDEX KEY: 0001000694
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222816046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9920 BELWARD CAMPUS DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 240-268-2000
MAIL ADDRESS:
STREET 1: 9920 BELWARD CAMPUS DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
doc4.xml
FORM 4 SUBMISSION
X0304
4
2012-03-01
0
0001000694
NOVAVAX INC
NVAX
0001129890
DRISCOLL FREDERICK W
9920 BELWARD CAMPUS DRIVE
ROCKVILLE
MD
20850
0
1
0
0
VP, CFO & Treasurer
Options-right to buy
1.28
2012-03-01
4
A
0
150000
1.28
A
2022-03-01
Common Stock
150000
580000
D
Options shall vest in four equal annual installments beginning on the first anniversary of the date of grant.
/s/ John Herrmann, Attorney-in-fact for Frederick W. Driscoll
2012-03-08